Baobing Zhao

14PUBLICATIONS
12CO-AUTHORS
Speciation and extinctionMolecular targetsMedical infection agents (incl. prions)Innate immunityHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 19, 2026
Autophagy: A Novel Therapeutic Target for Osteoporosis.

|May 05, 2026
Inhibition of Pellino-1 reverts the progression and tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

|Feb 27, 2026
Glycolytic-inflammatory crosstalk mediated by Glyco-PMF-Rux hub genes drives PMF progression and ruxolitinib resistance.

Shujing Zhang, Muhammad Sameer Ashaq, Yi Wang

|Jan 05, 2026
Integrative transcriptomics defines CD36 as a key regulator of immunometabolic signaling in acute myeloid leukemia.

Muhammad Sameer Ashaq, Qian Zhou, Yanxia Li

|Jul 19, 2025
Pleckstrin-2 promotes the progression of colorectal cancer via YTHDF2-mediated TYMS mRNA stability.

Qian Zhou, Yanxia Li, Xiaomei Li

|Jan 22, 2025
Fine-tuned calcium homeostasis is crucial for murine erythropoiesis.

Shujing Zhang, Yuanzhen Zhang, Yanxia Li

Pageof 3

Frequent Collaborators

2 joint publications

Yuan Li

2 joint publications

Li Meng

2 joint publications

Chunyan Ji

1 joint publications

Wei Zhang